Novel antioxidant approaches to the treatment of upper airway inflammation

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 1, 2010, Pages 34-41

  Braskett, Melinda ^a   Riedl, Marc A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway inflammation; Antioxidants; Novel therapeutics; Oxidative stress; Rhinosinusitis

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAFFEIC ACID PHENETHYL ESTER; CHOLINE; CURCUMIN; EPIGALLOCATECHIN GALLATE; ESCULETIN; GAMMA TOCOPHEROL; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXYGENASE; PG 102; PLACEBO; PROSTAGLANDIN SYNTHASE; RETINOL; SULFORAPHANE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; CELL INFILTRATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG INHIBITION; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC SUSCEPTIBILITY; HUMAN; HYPEROXIA; IMMUNOGLOBULIN PRODUCTION; INFLUENZA; LIVER TOXICITY; LOWER RESPIRATORY TRACT; LUNG INJURY; LUNG LAVAGE; MORTALITY; MUCUS SECRETION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ASTHMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; OXIDATIVE STRESS; RESPIRATORY SYSTEM;

EID: 76149113254     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328334f613     Document Type: Review

References (96)

1. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 2008; 122:456-468; quiz 69-70.
2. Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008; 8:49-56.
3. Dharajiya N, Boldogh I, Cardenas V, Sur S. Role of pollen NAD(P)H oxidase in allergic inflammation. Curr Opin Allergy Clin Immunol 2008; 8:57-62.
4. Kim TB, Moon KA, Lee KY, et al. Chlamydophila pneumoniae triggers release of CCL20 and vascular endothelial growth factor from human bronchial epithelial cells through enhanced intracellular oxidative stress and MAPK activation. J Clin Immunol 2009; 29:629-636.
5. Cho HY, Jedlicka AE, Reddy SP, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002; 26:175-182.
6. Li N, Venkatesan MI, Miguel A, et al. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol 2000; 165:3393-3401.
7. Li N, Hao M, Phalen RF, et al. Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects. Clin Immunol 2003; 109:250-265.
8. Diaz-Sanchez D, Garcia MP, Wang M, et al. Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa. J Allergy Clin Immunol 1999; 104:1183-1188.
9. Cekin E, Ipcioglu OM, Erkul BE, et al. The association of oxidative stress and nasal polyposis. J Int Med Res 2009; 37:325-330.
10. Deroee AF, Naraghi M, Sontou AF, et al. Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery. Am J Rhinol Allergy 2009; 23:159-161.
11. Gratziou C, Rovina N, Makris M, et al. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol 2008; 21:949-957.
12. Tanou K, Koutsokera A, Kiropoulos TS, et al. Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking. Clin Exp Allergy 2009; 39:345-353.
13. Woo HJ, Bae CH, Song SY, et al. Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am J Rhinol Allergy 2009; 23:288-293.
14. Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007; 62:378-384.
15. Linn WS, Rappaport EB, Berhane KT, et al. Exhaled nitric oxide in a population- based study of southern California schoolchildren. Respir Res 2009; 10:28.
16. Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res 2007; 56:58-69.
17. North ML, Khanna N, Marsden PA, et al. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296:L911-L920.
18. Profita M, La Grutta S, Carpagnano E, et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006; 118:1068-1074.
19. Rolla G, Guida G, Heffler E, et al. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest 2007; 131:1345-1352.
20. Silkoff PE, Erzurum SC, Lundberg JO, et al. ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006; 3:131-145.
21. Stark H, Purokivi M, Kiviranta J, et al. Short-term and seasonal variations of exhaled and nasal NO in healthy subjects. Respir Med 2007; 101:265-271.
22. Kenyon NJ, Liu R, O'Roark EM, et al. An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice. Eur J Pharmacol 2009; 603:138-146.
23. Lee M, Kim S, Kwon OK, et al. Anti-inflammatory and antiasthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol 2009; 9:418-424.
24. Onogawa M, Sun G, Takuma D, et al. Animal studies supporting the inhibition of mast cell activation by Eriobotrya japonica seed extract. J Pharm Pharmacol 2009; 61:237-241.
25. Kim D, Kim SH, Park EJ, et al. Antiallergic effects of PG102, a water-soluble extract prepared from Actinidia arguta, in a murine ovalbumin-induced asthma model. Clin Exp Allergy 2009; 39:280-289.
26. Li N, Wang M, Bramble LA, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect 2009; 117:1116-1123.
27. Mabalirajan U, Dinda AK, Sharma SK, Ghosh B. Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model. J Immunol 2009; 183:2059-2067.
28. Hung CH, Hua YM, Hsu WT, et al. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Pediatr Int 2007; 49:322-327.
29. Rocksen D, Lilliehook B, Larsson R, et al. Differential anti-inflammatory and antioxidative effects of dexamethasone and N-acetylcysteine in endotoxininduced lung inflammation. Clin Exp Immunol 2000; 122:249-256.
30. Westerveld GJ, Scheeren RA, Dekker I, et al. Antioxidant actions of oxymethazoline and xylomethazoline. Eur J Pharmacol 1995; 291:27-31.
31. Comhair SA, Bhathena PR, Dweik RA, et al. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000; 355:624.
32. Kelly FJ, Mudway I, Blomberg A, et al. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354:482-483.
33. Smith LJ, Houston M, Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 1993; 147:1461-1464.
34. Fitzpatrick AM, Teague WG, Holguin F, et al. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol 2009; 123:146.e8-152.e8.
35. Levy M, Khan E, Careaga M, Goldkorn T. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 2009; 297:L125-L133.
36. Blake DJ, Singh A, Kombairaju P, et al. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol 2009 Jun 11. [Epub ahead of print]
37. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992; 43:667-669.
38. Atkuri KR, Mantovani JJ, Herzenberg LA. N-Acetylcysteine: a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007; 7:355-359.
39. Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr 1993; 58:103-105.
40. Lenton KJ, Sane AT, Therriault H, et al. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr 2003; 77:189-195.
41. Dharajiya N, Choudhury BK, Bacsi A, et al. Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation. J Allergy Clin Immunol 2007; 119:646-653.
42. Whitekus MJ, Li N, Zhang M, et al. Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J Immunol 2002; 168:2560-2567.
43. Domenighetti G, Suter PM, Schaller MD, et al. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care 1997; 12:177-182.
44. Konrad F, Schoenberg MH, Wiedmann H, et al. The application of nacetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients: a prospective, randomized, placebo-controlled, double-blind study. Anaesthesist 1995; 44:651-658.
45. Suter PM, Domenighetti G, Schaller MD, et al. N-acetylcysteine enhances recovery from acute lung injury in man: a randomized, double-blind, placebocontrolled clinical study. Chest 1994; 105:190-194.
46. Moradi M, Mojtahedzadeh M, Mandegari A, et al. The role of glutathione-Stransferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med 2009; 103:434-441.
47. Almolki A, Taille C, Martin GF, et al. Heme oxygenase attenuates allergeninduced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol 2004; 287:L26-L34.
48. Hashiba T, Suzuki M, Nagashima Y, et al. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther 2001; 8:1499-1507.
49. Hisada T, Salmon M, Nasuhara Y, Chung KF. Involvement of haemoxygenase-1 in ozone-induced airway inflammation and hyperresponsiveness. Eur J Pharmacol 2000; 399:229-234.
50. Jia YX, Sekizawa K, Okinaga S, et al. Role of heme oxygenase in pulmonary response to antigen challenge in sensitized rats in vivo. Int Arch Allergy Immunol 1999; 120:141-145.
51. Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103:1047-1054.
52. Lee IT, Luo SF, Lee CW, et al. Overexpression of HO-1 protects against TNFalpha- mediated airway inflammation by down-regulation of TNFR1-dependent oxidative stress. Am J Pathol 2009; 175:519-532.
53. Almolki A, Guenegou A, Golda S, et al. Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am J Pathol 2008; 173:981-992.
54. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and antiinflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28:1303-1312.
55. Scapagnini G, Foresti R, Calabrese V, et al. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 2002; 61:554-561.
56. Heo HJ, Lee SY, Lee MN, et al. Genistein and curcumin suppress epidermal growth factor-induced MUC5AC mucin production and gene expression from human airway epithelial cells. Phytother Res 2009; 23:1458-1461.
57. Moon DO, Kim MO, Lee HJ, et al. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem Biophys Res Commun 2008; 375:275-279.
58. Jung WK, Lee DY, Choi YH, et al. Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sci 2008; 82:797-805.
59. Grattagliano I, Vendemiale G, Caraceni P, et al. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J Nutr 2000; 130:2131-2136.
60. Yoshida Y, Itoh N, Hayakawa M, et al. Lipid peroxidation in mice fed a cholinedeficient diet as evaluated by total hydroxyoctadecadienoic acid. Nutrition 2006; 22:303-311.
61. Askwith T, Zeng W, Eggo MC, Stevens MJ. Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy. Am J Physiol Endocrinol Metab 2009; 297:E620-E628.
62. Lee WY, Orestes P, Latham J, et al. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J Neurosci 2009; 29:9500-9509.
63. Cho YS, Lee J, Lee TH, et al. alpha-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Allergy Clin Immunol 2004; 114:429-435.
64. Lee KS, Kim SR, Park SJ, et al. Antioxidant down-regulates interleukin-18 expression in asthma. Mol Pharmacol 2006; 70:1184-1193.
65. Mehta AK, Arora N, Gaur SN, Singh BP. Choline supplementation reduces oxidative stress in mouse model of allergic airway disease. Eur J Clin Invest 2009; 39:934-941.
66. Devereux G, Turner SW, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006; 174:499-507.
67. Papas KA, Sontag MK, Pardee C, et al. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J Cyst Fibros 2008; 7:60-67.
68. Pearson PJ, Lewis SA, Britton J, Fogarty A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax 2004; 59:652-656.
69. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, et al. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004; 59:8-10.
70. Shahar E, Hassoun G, Pollack S. Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004; 92:654-658.
71. Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, et al. Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone. Clin Exp Immunol 2004; 138:317-322.
72. Dunstan JA, Breckler L, Hale J, et al. Supplementation with vitamins C, E, betacarotene and selenium has no effect on antioxidant status and immune responses in allergic adults: a randomized controlled trial. Clin Exp Allergy 2007; 37:180-187.
73. Hernandez M, Zhou H, Zhou B, et al. Combination treatment with high-dose vitamin C and alpha-tocopherol does not enhance respiratory-tract lining fluid vitamin C levels in asthmatics. Inhal Toxicol 2009; 21:173-181.
74. Behndig AF, Blomberg A, Helleday R, et al. Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C. Inhal Toxicol 2009; 21:250-258.
75. Cho DY, Hwang PH, Illek B. Effect of L-ascorbate on chloride transport in freshly excised sinonasal epithelia. Am J Rhinol Allergy 2009; 23:294-299.
76. Baumeister P, Korn G, Berghaus A, et al. Chemopreventive action of dexamethasone and alpha-tocopherol in oxidative stressed cells. Cancer Detect Prev 2009; 32:452-457.
77. Reiter M, Rupp K, Baumeister P, et al. Antioxidant effects of quercetin and coenzyme Q10 in mini organ cultures of human nasal mucosa cells. Anticancer Res 2009; 29:33-39.
78. Wagner JG, Jiang Q, Harkema JR, et al. Gamma-tocopherol prevents airway eosinophilia and mucous cell hyperplasia in experimentally induced allergic rhinitis and asthma. Clin Exp Allergy 2008; 38:501-511.
79. Mabalirajan U, Aich J, Leishangthem GD, et al. Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model. J Appl Physiol 2009; 107:1285-1292.
80. Munday R, Mhawech-Fauceglia P, Munday CM, et al. Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res 2008; 68:1593-1600.
81. Talalay P, Fahey JW, Healy ZR, et al. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci U S A 2007; 104:17500-17505.
82. Wan J, Diaz-Sanchez D. Phase II enzymes induction blocks the enhanced IgE production in B cells by diesel exhaust particles. J Immunol 2006; 177:3477-3483.
83. Riedl MA, Saxon A, Diaz-Sanchez D. Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009; 130: 244-251.
84. Ho CT, Chen Q, Shi H, et al. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 1992; 21:520-525.
85. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001; 479:197-206.
86. Kim HJ, Park SH, Park SYet al. Epigallocatechin-3-gallate inhibits interleukin- 1beta-induced MUC5AC gene expression and MUC5AC secretion in normal human nasal epithelial cells. J Nutr Biochem 2008; 19:536-544.
87. Lee BC, Lee SY, Lee HJ, et al. Antioxidative and photo-protective effects of coumarins isolated from Fraxinus chinensis. Arch Pharm Res 2007; 30:1293-1301.
88. Mirzoeva OK, Calder PC. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot Essent Fatty Acids 1996; 55:441-449.
89. Natarajan K, Singh S, Burke TR Jr, et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NFkappa B. Proc Natl Acad Sci U S A 1996; 93:9090-9095.
90. Sud'ina GF, Mirzoeva OK, Pushkareva MA, et al. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329:21-24.
91. Riedl MA. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep 2008; 8:139-146.
92. Yang IA, Fong KM, Zimmerman PV, et al. Genetic susceptibility to the respiratory effects of air pollution. Thorax 2008; 63:555-563.
93. Islam T, Berhane K, McConnell R, et al. Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 2009; 64:197-202.
94. Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, et al. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 2006; 28:953-959.
95. Gilliland FD, Li YF, Saxon A, Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 2004; 363:119-125.
96. Cahill LE, Fontaine-Bisson B, El-Sohemy A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am J Clin Nutr 2009; 90:1411-1417.